Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells
about
eEF-2 Phosphorylation Down-Regulates P-Glycoprotein Over-Expression in Rat Brain Microvessel Endothelial CellsGlutamine promotes ovarian cancer cell proliferation through the mTOR/S6 pathway.Vitamin D, intermediary metabolism and prostate cancer tumor progression.Glutamate and its receptors in cancerMetabotropic glutamate receptor 1 expression and its polymorphic variants associate with breast cancer phenotypes.Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomasIdentification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues.Prioritizing candidate disease metabolites based on global functional relationships between metabolites in the context of metabolic pathways.Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis.(18)F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancerGlutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.Glutamate, glutamate receptors, and downstream signaling pathwaysMetabotropic glutamate receptor 1 disrupts mammary acinar architecture and initiates malignant transformation of mammary epithelial cells.Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension.PDHA1 gene knockout in prostate cancer cells results in metabolic reprogramming towards greater glutamine dependence.Metabolic reprogramming and validation of hyperpolarized 13C lactate as a prostate cancer biomarker using a human prostate tissue slice culture bioreactorA Novel [15N] Glutamine Flux using LC-MS/MS-SRM for Determination of Nucleosides and Nucleobases.Diagnosis of prostate cancer by desorption electrospray ionization mass spectrometric imaging of small metabolites and lipidsMetabotropic glutamate receptor 1 acts as a dependence receptor creating a requirement for glutamate to sustain the viability and growth of human melanomas.Riluzole exerts distinct antitumor effects from a metabotropic glutamate receptor 1-specific inhibitor on breast cancer cells.Fluorodeoxyglucose positron emission tomography may aid the diagnosis of aggressive primary prostate cancer: A case series study.Glutamate, a metabolic biomarker of aggressiveness and a potential therapeutic target for prostate cancer.Urine and Serum Metabolomics Analyses May Distinguish between Stages of Renal Cell CarcinomaAutocrine, paracrine and necrotic NMDA receptor signalling in mouse pancreatic neuroendocrine tumour cells.Glutaminolysis drives membrane trafficking to promote invasiveness of breast cancer cells.68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans.Regulation of Cancer Stem Cell Metabolism by Secreted Frizzled-Related Protein 4 (sFRP4).A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.Tissue metabolite profiling identifies differentiating and prognostic biomarkers for prostate carcinoma.Gelsolin-like actin-capping protein is associated with patient prognosis, cellular apoptosis and proliferation in prostate cancer.NMDA receptors mediate contractile responses in human airway smooth muscle cells.[The cancer paradigm in pulmonary arterial hypertension: towards anti-remodeling therapies targeting metabolic dysfunction?]Small interfering RNA-mediated knockdown of fatty acid synthase attenuates the proliferation and metastasis of human gastric cancer cells via the mTOR/Gli1 signaling pathway.Participation of xCT in melanoma cell proliferation in vitro and tumorigenesis in vivo
P2860
Q28576105-7D29F92B-AD12-43FC-A6B6-2097B2BBDB33Q30371587-0E50297F-F847-4231-9DB7-32ABAC4056CEQ33647013-5982D2C0-EEE3-476F-8162-67036C2BB8C0Q34048497-64DFF4A4-8180-4276-89DC-108AC5BF0F9DQ34904277-58072C45-70E4-43DB-9048-F394C548AC48Q35103343-35058446-5E4A-4719-99E9-EE5A2D0FC78DQ35213199-F322AAF3-4A25-4483-8DBB-8591F48C6294Q35231088-84B96C6F-F2A7-478C-951A-99ECC138736CQ35752074-739E4044-D066-4911-8CE6-DBEB995BDE19Q36502692-A8292B66-FA31-4A72-886A-34A2937313E2Q36722097-5F753CB8-BEDB-4A3C-A19D-0A385E1CA4D9Q37121338-3382C3CD-56D2-4E50-B756-A104A9480F61Q37249255-F1C81C6B-256A-4F53-9D74-B27CCD5DD8F8Q37540105-A12AF3BF-1CF4-4525-9CCC-D34C941BC4EAQ37619276-3B8EFE7B-FC8E-41C5-B538-6D52E4F68065Q37619836-C1284B45-F032-4039-A58C-7A0C919E3F4CQ37686102-0BE24790-583B-4C7C-ACEE-6241567E0D2FQ38772300-92A3E860-635B-4C30-B69B-95ADE147F0B2Q38908321-D3D4E06E-C052-4A8B-893F-F91731CFAC0AQ38971337-E9424BA1-0970-4579-9F8F-8C94D41380E3Q41280249-9CF840DF-9178-4831-89E6-9EA7F47FBC76Q41852965-E92A02E2-63EC-4E4B-842D-381AC1B7D747Q42140458-4E5B3A2D-C449-4254-9F44-7E73C584CB9EQ42293369-96BE784E-9357-4C31-A460-56807D9FDE59Q47142464-A6290ED5-8749-4446-B479-8DD2FFA0D8E0Q47169465-534D1566-6822-46DF-A596-2B6578633F9DQ47660762-F0A9CDFE-1D13-40EE-9268-427F1F0FDBA8Q48133992-9F87CE8B-5E50-4E80-A2E7-935AF626B623Q49907440-1A6C1FF6-414F-4C49-A2B0-98A0CD50DD38Q50936284-0C6449E5-DD2B-4A07-A044-ADA20B4D116DQ51281894-71719111-E1DA-4B71-B77E-F9F01ADA844DQ51639133-9AC6130F-4A72-48F6-A88C-A3551A319E85Q52312423-CC7D6BAD-E508-4919-950B-385084F73F96Q55431895-FC0134CC-2D44-4DB8-A535-09FB56423BF7Q59137905-2B9AB0A4-092A-4AC9-B373-B51661B86063
P2860
Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cells
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Serum glutamate levels correla ...... tosis in prostate cancer cells
@ast
Serum glutamate levels correla ...... tosis in prostate cancer cells
@en
type
label
Serum glutamate levels correla ...... tosis in prostate cancer cells
@ast
Serum glutamate levels correla ...... tosis in prostate cancer cells
@en
prefLabel
Serum glutamate levels correla ...... tosis in prostate cancer cells
@ast
Serum glutamate levels correla ...... tosis in prostate cancer cells
@en
P2093
P2860
P1476
Serum glutamate levels correla ...... tosis in prostate cancer cells
@en
P2093
Charles Manhardt
Dhatchayini Subramani
Giovanni D Lorusso
Gissou Azabdaftari
Hillary Thompson
James L Mohler
Katayoon Rezaei
Kristopher Attwood
Mojgan Shourideh
Oliver Sartor
P2860
P304
P356
10.1158/1078-0432.CCR-12-1308
P407
P577
2012-10-16T00:00:00Z